BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33220098)

  • 1. Dual role of B7-H6 as a novel prognostic marker in hepatocellular carcinoma.
    Qiu H; Gao S; Sun Z; Wang J
    APMIS; 2021 Mar; 129(3):105-117. PubMed ID: 33220098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of the Immunologic Co-Stimulator B7 and TNFR Families Correlate with Hepatocellular Carcinoma Prognosis and Metastasis by Inactivating STAT3.
    Li YM; Liu ZY; Li ZC; Wang JC; Yu JM; Yang HJ; Chen ZN; Tang J
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30609841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cells.
    Fiegler N; Textor S; Arnold A; Rölle A; Oehme I; Breuhahn K; Moldenhauer G; Witzens-Harig M; Cerwenka A
    Blood; 2013 Aug; 122(5):684-93. PubMed ID: 23801635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of B7-H6 in esophageal squamous cell carcinoma.
    Zhou H; Dong J; Guo L; Wang X; Wang K; Cai X; Yang S
    Sci Rep; 2019 Dec; 9(1):18122. PubMed ID: 31792298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NKP30-B7-H6 Interaction Aggravates Hepatocyte Damage through Up-Regulation of Interleukin-32 Expression in Hepatitis B Virus-Related Acute-On-Chronic Liver Failure.
    Zou Y; Bao J; Pan X; Lu Y; Liao S; Wang X; Wang G; Lin D
    PLoS One; 2015; 10(8):e0134568. PubMed ID: 26241657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression, crystallization and X-ray diffraction analysis of a complex between B7-H6, a tumor cell ligand for the natural cytotoxicity receptor NKp30, and an inhibitory antibody.
    Xu X; Li Y; Gauthier L; Chen Q; Vivier E; Mariuzza RA
    Acta Crystallogr F Struct Biol Commun; 2015 Jun; 71(Pt 6):697-701. PubMed ID: 26057798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B7-H6 protein expression has no prognostic significance in human gastric carcinoma.
    Chen XJ; Shen J; Zhang GB; Chen WC
    Pathol Oncol Res; 2014 Jan; 20(1):203-7. PubMed ID: 24242703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients.
    Semeraro M; Rusakiewicz S; Minard-Colin V; Delahaye NF; Enot D; Vély F; Marabelle A; Papoular B; Piperoglou C; Ponzoni M; Perri P; Tchirkov A; Matta J; Lapierre V; Shekarian T; Valsesia-Wittmann S; Commo F; Prada N; Poirier-Colame V; Bressac B; Cotteret S; Brugieres L; Farace F; Chaput N; Kroemer G; Valteau-Couanet D; Zitvogel L
    Sci Transl Med; 2015 Apr; 7(283):283ra55. PubMed ID: 25877893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secreted Ligands of the NK Cell Receptor NKp30: B7-H6 Is in Contrast to BAG6 Only Marginally Released via Extracellular Vesicles.
    Ponath V; Hoffmann N; Bergmann L; Mäder C; Alashkar Alhamwe B; Preußer C; Pogge von Strandmann E
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity Maturation of B7-H6 Translates into Enhanced NK Cell-Mediated Tumor Cell Lysis and Improved Proinflammatory Cytokine Release of Bispecific Immunoligands via NKp30 Engagement.
    Pekar L; Klausz K; Busch M; Valldorf B; Kolmar H; Wesch D; Oberg HH; Krohn S; Boje AS; Gehlert CL; Toleikis L; Krah S; Gupta T; Rabinovich B; Zielonka S; Peipp M
    J Immunol; 2021 Jan; 206(1):225-236. PubMed ID: 33268483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B7-H6 expression in non-small cell lung cancers.
    Zhang X; Zhang G; Qin Y; Bai R; Huang J
    Int J Clin Exp Pathol; 2014; 7(10):6936-42. PubMed ID: 25400778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficient Natural Killer Cell NKp30-Mediated Function and Altered NCR3 Splice Variants in Hepatocellular Carcinoma.
    Mantovani S; Oliviero B; Lombardi A; Varchetta S; Mele D; Sangiovanni A; Rossi G; Donadon M; Torzilli G; Soldani C; Porta C; Pedrazzoli P; Chiellino S; Santambrogio R; Opocher E; Maestri M; Bernuzzi S; Rossello A; Clément S; De Vito C; Rubbia-Brandt L; Negro F; Mondelli MU
    Hepatology; 2019 Mar; 69(3):1165-1179. PubMed ID: 30153337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metalloprotease-mediated tumor cell shedding of B7-H6, the ligand of the natural killer cell-activating receptor NKp30.
    Schlecker E; Fiegler N; Arnold A; Altevogt P; Rose-John S; Moldenhauer G; Sucker A; Paschen A; von Strandmann EP; Textor S; Cerwenka A
    Cancer Res; 2014 Jul; 74(13):3429-40. PubMed ID: 24780758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mimicking an induced self phenotype by coating lymphomas with the NKp30 ligand B7-H6 promotes NK cell cytotoxicity.
    Kellner C; Maurer T; Hallack D; Repp R; van de Winkel JG; Parren PW; Valerius T; Humpe A; Gramatzki M; Peipp M
    J Immunol; 2012 Nov; 189(10):5037-46. PubMed ID: 23066150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Significance of B7-H3 Expression During the Progression of Hepatitis B Virus Infection.
    Gao F; Xu JC; Zhu L; Chen H; Zhu XY; You XR; Li SX; Zhu CL; Yang C; Zhu CW; Xu P
    Viral Immunol; 2018 Dec; 31(10):668-675. PubMed ID: 30481143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canopy Homolog 2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma with Tumor Hemorrhage.
    Wang D; Wang ZM; Zhang S; Wu HJ; Tao YM
    Cell Physiol Biochem; 2018; 50(6):2017-2028. PubMed ID: 30415246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence.
    Sun TW; Gao Q; Qiu SJ; Zhou J; Wang XY; Yi Y; Shi JY; Xu YF; Shi YH; Song K; Xiao YS; Fan J
    Cancer Immunol Immunother; 2012 Nov; 61(11):2171-82. PubMed ID: 22729558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
    World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The B7 Family Member B7-H6: a New Bane of Tumor.
    Chen Y; Mo J; Jia X; He Y
    Pathol Oncol Res; 2018 Oct; 24(4):717-721. PubMed ID: 29086181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Insights into the Inhibitory Mechanism of an Antibody against B7-H6, a Stress-Induced Cellular Ligand for the Natural Killer Cell Receptor NKp30.
    Xu X; Narni-Mancinelli E; Cantoni C; Li Y; Guia S; Gauthier L; Chen Q; Moretta A; Vély F; Eisenstein E; Rangarajan S; Vivier E; Mariuzza RA
    J Mol Biol; 2016 Nov; 428(22):4457-4466. PubMed ID: 27663271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.